Anti-inflammatory medications are a cornerstone of treatment for mixed connective tissue disease (MCTD) but your diet also is important. Eating foods that suppress inflammation may help prevent ...

The incidence and prevalence of CTD-ILD in the US is most common among women and older individuals, affecting approximately 116,000 to 118,000 adults.

Today, AliveDx announces it has submitted 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for the MosaiQ AiPlex® Connective Tissue Diseases (CTDplus) microarray. The ...

Researchers found no association between anti-U1RNP autoantibodies and 3-year ILD progression or mortality in patients with ...

Mixed Connective Tissue disease." The Johns Hopkins Medicine describes Polymyositis as a disease that causes muscles to become irritated and inflamed.

Other connective-tissue disorders. ... Mixed Connective Tissue Disease, The Digestive Involvement in Systemic Autoimmune Diseases, (321-332), (2017) ...

EYSINS, Switzerland, Feb. 3, 2025 /PRNewswire/ -- AliveDx announces the receipt of IVDR-CE mark for its MosaiQ AiPlex ® CTDplus multiplex assay. The multiplex assay enables a syndromic approach ...

EYSINS, Switzerland, April 3, 2025 /PRNewswire/ --Today, AliveDx announces it has submitted 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for the MosaiQ AiPlex ...

EYSINS, Switzerland, April 3, 2025 /PRNewswire/ -- Today, AliveDx announces it has submitted 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for the MosaiQ AiPlex® ...

/PRNewswire/ -- Today, AliveDx announces it has submitted 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for the MosaiQ AiPlex® ...